2011 Articles
Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
Appolonova SA, Baranov PA, Mesonzhnik NV, Brazhnikova DO, Rodchenkov GM.
Drug Test. Anal., 2011, 3, 717–723.
Abstract
Easy stereoselective synthesis of 5α-estrane-3β,17α-diol, the major metabolite of nandrolone in the horse.
Balssa F, Fischer M, Bonnaire Y.
Steroids, 2011, 76, 667–668.
Abstract
Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control.
Boyard-Kieken F, Dervilly-Pinel G, Garcia P, Paris AC, Popot MA, le Bizec B, Bonnaire Y.
J. Sep. Sci., 2011, 34, 3493–3501.
Abstract
Screen and confirmation of PEG-epoetin β in equine plasma.
Chang Y, Maylin GM, Matsumoto G, Neades SM, Catlin DH.
Drug Test. Anal., 2011, 3, 68–73.
Abstract
The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
Clarke A, Scarth J, Teale P, Pearce C, Hillyer L.
Drug Test. Anal., 2011, 3, 74–87.
Abstract
Determination of firocoxib in equine plasma using high performance liquid chromatography.
Cox S, Yarbrough J.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879, 205–208.
Abstract
The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses.
Davis JL, Marshall JF, Papich MG, Blikslager AT, Campbell NB.
J. Vet. Pharmacol. Ther., 2011, 34, 12–16.
Abstract
Pharmacokinetics and metabolism of dantrolene in horses.
DiMaio Knych HK, Arthur RM, Taylor A, Moeller BC, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 238–46.
Abstract
Pharmacokinetics of yohimbine following intravenous administration to horses.
Dimaio Knych HK, Steffey EP, Deuel JL, Shepard RA, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 58–63.
Abstract
Pharmacokinetics and pharmacodynamics of three intravenous doses of yohimbine in the horse.
Dimaio Knych HK, Steffey EP, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 359–366.
Abstract
In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.
Fenwick SJ, Scarth JP.
Drug Test. Anal., 2011, 3, 705–716.
Abstract
Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
Frazier SA, McKemie DS, Guerrero TA, Skorupski KA, Rodriguez CO Jr.
Am. J. Vet. Res., 2011, 72, 263–70.
Abstract
Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.
Garcia P, Paris AC, Gil J, Popot MA, Bonnaire Y.
Biomed. Chromatogr., 2011, 25, 147–154.
Abstract
Oral administration of tepoxalin in the horse: A PK/PD study.
Giorgi M, Cuniberti B, Ye G, Barbero R, Sgorbini M, Vercelli C, Corazza M, Re G.
Vet. J., 2011, 190, 143–149.
Abstract
Characterization of in vivo plasma metabolites of tepoxalin in horses using LC–MS–MS.
Giorgia M, Mengozzia G, Raffaellib A, Saba A.
J. Pharm. Biomed. Anal., 2011, 56, 45–53.
Abstract
The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse.
Goodwin WA, Keates HL, Pasloske K, Pearson M, Sauer B, Ranasinghe MG.
Vet. Anaesth. Analg., 2011, 38, 431–438.
Abstract
Analysis of methyloxime derivatives of intact esters of testosterone and boldenone in equine plasma using ultra high performance liquid chromatography tandem mass spectrometry.
Gray BP, Teale P, Pearce CM.
Drug Test. Anal., 2011, 3, 206–213.
Abstract
Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry.
Ho EN, Wan TS, Wong AS, Lam KK, Stewart BD.
J. Chromatogr. A, 2011, 1218, 1139–1146.
Abstract
Simultaneous determination of codeine, ephedrine, guaiphenesin and chlorpheniramine in beagle dog plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: Application to a bioequivalence study.
Hu Z, Zou Q, Tian J, Sun L, Zhang Z.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879, 3937–3942.
Abstract
Advances in equine sports testing.
Kuuranne T.
Drug Test. Anal., 2011, 3, 18.
Abstract
Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in beagle dogs.
Lavy E, Prise U, Soldani G, Neri D, Brandriss N, Chaim AB, Giorgi M.
Vet. J., 2011, 189, 336–340.
Abstract
Identification of cryptorchidism in horses by analysing urine samples with gas chromatography/mass spectrometry.
Leung DKK, Tang FPW, Wan TSM.
Vet. J., 2011, 187, 60–64.
Abstract
Efficient use of retention time for the analysis of 302 drugs in equine plasma by LC-MS/MS with scheduled multiple reaction monitoring and instant library search.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Chen J.
Anal. Chem., 2011, 83, 6834–6841.
Abstract
Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography-tandem mass spectrometry with instant library searching.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Rudy JA, Chen JW.
Drug Test. Anal., 2011, 3, 54–67.
Abstract
Analysis of gabapentin in equine plasma with measurement uncertainty estimation by liquid chromatography-tandem mass spectrometry.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Rudy JA, Chen JW.
J. Anal. Toxicol., 2011, 35, 75–84.
Abstract
Horse metabolism and the photocatalytic process as a tool to identify metabolic products formed from dopant substances: the case of sildenafil.
Medana C, Calza P, Giancotti V, Dal Bello F, Pasello E, Montana M, Baiocchi C.
Drug Test. Anal., 2011, 3, 724–734.
Abstract
Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
Messenger KM, Davis JL, Lafevers DH, Barlow BM, Posner LP.
Vet. Anaesth. Analg., 2011, 38, 374–384.
Abstract
An interlaboratory study of the pharmacokinetics of testosterone following intramuscular administration to thoroughbred horses.
Moeller BC, Sams RA, Guinjab J, Szabo N, Colahan P, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 588–593.
Abstract
The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital.
Moore SA, Muñana KR, Papich MG, Nettifee-Osborne JA.
J. Vet. Pharmacol. Ther., 2011, 34, 31–34.
Abstract
Use of benchtop Exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control.
Moulard Y, Bailly-Chouriberry L, Boyer S, Garcia P, Popot MA, Bonnaire Y.
Anal. Chim. Acta, 2011, 700, 126–136.
Abstract
Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs.
Musulin SE, Mariani CL, Papich MG.
J. Vet. Pharmacol. Ther., 2011, 34, 17–24.
Abstract
Doping control in horses: housing conditions and oral recycling of flunixin by ingestion of contaminated straw.
Popot MA, Garcia P, Bonnaire Y.
J. Vet. Pharmacol. Ther., 2011, 34, 612–614.
Abstract
Validation of a liquid chromatography-tandem mass spectrometry method for quantification of glycopyrrolate in horse plasma.
Rumpler MJ, Sams RA, Colahan P
J. Anal. Toxicol., 2011, 35, 656–654.
Abstract
Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.
Rumpler MJ, Sams RA, Colahan P.
J. Vet. Pharmacol. Ther., 2011, 34, 605–608.
Abstract
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Saccomanni G, Giorgi M, Del Carlo S, Manera C, Saba A, Macchia M.
Anal. Bioanal. Chem., 2011, 401, 1677–1684.
Abstract
Drug metabolism in the horse: a review.
Scarth JP, Teale P, Kuuranne T.
Drug Test. Anal., 2011, 3, 19–53.
Abstract
Plasma concentrations of testosterone and nandrolone in racing and nonracing intact male horses.
Soma LR, Uboh CE, You Y, Guan F, McDonnell S.
J. Vet. Pharmacol. Ther., 2011, 35, 132–138.
Abstract
Detection of various performance enhancing substances in specimens collected from race horses in Illinois: a five-year experience.
Taddei L, Benoit M, Sukta A, Peterson J, Gaensslen RE, Negrusz A.
J. Anal. Toxicol., 2011, 35, 438–443.
Abstract
The pharmacokinetics and metabolism of meloxicam in camels after intravenous administration.
Wasfi IA, Al Ali WA, Agha BA, Kamel AM, Al Biriki NA, Al Neaimi M.
J. Vet. Pharmacol. Ther., 2011, 35, 155–162.
Abstract
The pharmacokinetics of hydrochlorothiazide in the camel.
Wasfi IA, Al Katheeri NA.
J. Vet. Pharmacol. Ther., 2011, 34, 518–520.
Abstract
Elimination and phase II metabolism of ethanol in camels after intravenous administration.
Wasfi IA, Kamel AM, Saeed HM, Saleh NA, Wajid S, Al Katheeri NA, Agha BA.
Vet. J., 2011, 189, 95–99.
Abstract
Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ.
J. Vet. Pharmacol. Ther., 2011, 34, 252–258.
Abstract
A broad-spectrum equine urine screening method for free and enzyme-hydrolysed conjugated drugs with ultra performance liquid chromatography/tandem mass spectrometry.
Wong CHF, Tang FPW, Wan TSM.
Anal. Chim. Acta, 2011, 697, 48–60.
Abstract
In vitro metabolic studies using homogenized horse liver in place of horse liver microsomes.
Wong JKY, Tang FPW, Wan TSM.
Drug Test. Anal., 2011, 3, 393–399.
Abstract